These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37623428)

  • 1. Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
    Meekers E; Dauw J; Martens P; Dhont S; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur Heart J; 2023 Oct; 44(37):3672-3682. PubMed ID: 37623428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
    Verbrugge FH; Martens P; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W
    J Am Coll Cardiol; 2023 May; 81(20):2013-2024. PubMed ID: 37197845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
    N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
    Martens P; Verbrugge FH; Dauw J; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Heylen L; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur Heart J; 2023 Jun; 44(22):1995-2005. PubMed ID: 37138385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
    Van den Eynde J; Martens P; Dauw J; Nijst P; Meekers E; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W; Verbrugge FH
    Circ Heart Fail; 2024 Oct; 17(10):e011749. PubMed ID: 39171394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial.
    Dhont S; Martens P; Meekers E; Dauw J; Verbrugge FH; Nijst P; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Eur J Heart Fail; 2023 Aug; 25(8):1310-1319. PubMed ID: 37062871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
    Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and natriuresis-guided diuretic therapy - a pre-specified analysis from the PUSH-AHF trial.
    Damman K; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Ter Maaten JM
    Eur J Heart Fail; 2024 Jun; 26(6):1347-1357. PubMed ID: 38734982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.
    Kula AJ; Hanberg JS; Wilson FP; Brisco MA; Bellumkonda L; Jacoby D; Coca SG; Parikh CR; Tang WHW; Testani JM
    Circ Heart Fail; 2016 Jan; 9(1):e002333. PubMed ID: 26699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
    Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
    Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.
    Packer M; Butler J
    Eur J Heart Fail; 2023 Sep; 25(9):1537-1543. PubMed ID: 37403655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d across eGFR levels.
    Rospert D; Molony DA
    Ann Intern Med; 2024 Jan; 177(1):JC2. PubMed ID: 38163366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Milbradt TL; Sudo RYU; Gobbo MODS; Akinfenwa S; Moura B
    Heart Fail Rev; 2024 Sep; 29(5):1039-1047. PubMed ID: 38985385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening renal function in acute heart failure in the context of diuretic response.
    Emmens JE; Ter Maaten JM; Matsue Y; Figarska SM; Sama IE; Cotter G; Cleland JGF; Davison BA; Felker GM; Givertz MM; Greenberg B; Pang PS; Severin T; Gimpelewicz C; Metra M; Voors AA; Teerlink JR
    Eur J Heart Fail; 2022 Feb; 24(2):365-374. PubMed ID: 34786794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of congestion with worsening renal function in acute decompensated heart failure according to age.
    Odajima S; Fujimoto W; Kuroda K; Yamashita S; Imanishi J; Iwasaki M; Todoroki T; Okuda M; Hayashi T; Konishi A; Shinohara M; Toh R; Hirata KI; Tanaka H
    ESC Heart Fail; 2022 Dec; 9(6):4250-4261. PubMed ID: 36113882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.
    Rao VS; Ahmad T; Brisco-Bacik MA; Bonventre JV; Wilson FP; Siew ED; Felker GM; Anstrom KK; Mahoney DD; Bart BA; Tang WHW; Velazquez EJ; Testani JM
    Circ Heart Fail; 2019 Jun; 12(6):e005552. PubMed ID: 31163974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion.
    Testani JM; Brisco MA; Chen J; McCauley BD; Parikh CR; Tang WH
    J Am Coll Cardiol; 2013 Aug; 62(6):516-24. PubMed ID: 23747773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.